MARKET

HALO

HALO

Halozyme Thrp
NASDAQ
77.18
+2.22
+2.96%
After Hours: 78.38 +1.2 +1.55% 19:55 06/29 EDT
OPEN
75.00
PREV CLOSE
74.96
HIGH
77.24
LOW
74.47
VOLUME
2.24M
TURNOVER
--
52 WEEK HIGH
82.22
52 WEEK LOW
51.06
MARKET CAP
9.15B
P/E (TTM)
27.76
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HALO last week (0622-0626)?
Weekly Report · 21h ago
ABSCI CORP (ABSI) Soars 36.0%: Is Further Upside Left in the Stock?
NASDAQ · 4d ago
LifeMD partners with Halozyme subsidiary for exclusive testosterone program
TipRanks · 06/22 13:43
LifeMD partners with Halozyme unit Antares to launch XYOSTED telehealth self-pay program in July 2026
PUBT · 06/22 12:01
Weekly Report: what happened at HALO last week (0615-0619)?
Weekly Report · 06/22 09:04
Did Expanding ENHANZE Partnerships and Cash Generation Just Shift Halozyme Therapeutics' (HALO) Investment Narrative?
Simply Wall St · 06/19 17:32
As corporate profit margins remain elevated, these mid-caps stand out
Seeking Alpha · 06/18 13:25
Halozyme Therapeutics (HALO) Stock Could Be 18.8% Undervalued As Partner Growth Lifts Sentiment
Simply Wall St · 06/17 16:28
More
About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing solutions to improve patient experiences and outcomes for emerging and established therapies. The Company's commercially-validated solution, ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, is used to facilitate the subcutaneous delivery of injected drugs and fluids, with a focus on improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine ENHANZE with its partners’ proprietary compounds. It also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED. It also has a proprietary ultra-high concentration microparticle formulation technology for biologics, branded Hypercon.

Webull offers Halozyme Therapeutics, Inc. stock information, including NASDAQ: HALO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HALO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HALO stock methods without spending real money on the virtual paper trading platform.